Two distinctive types of eosinophil chemotactic lymphokines (ECF-L) directed against eosinophils obtained from bone marrow (BM-Eo) or from peritoneal cavity (PEC-Eo) were isolated from the media conditioned by spleen cells from mice infected with Schistosoma japonicum by a combination of anion-exchange chromatography on DE52, affinity chromatography on Procion Red agarose, and high-performance liquid chromatography. The molecular weight of ECF-L directed against BM-Eo was 10,000 and that against PEC-Eo was 46,000 by SDS-PAGE analysis. After isolation, selectivity of the two distinct ECF-L was examined using BM-Eo, PEC-Eo and circulating Eo. ECF-L directed against BM-Eo could attract only BM-Eo, whereas that directed against PEC-Eo could attract not only PEC-Eo but also circulating Eo. Synthetic ECF-A was chemotactic against both BM- and circulating-Eo but not against PEC-Eo. When BM-Eo were cultured with ECF-L selective to PEC-Eo, they became reactive to ECF-L selective to PEC-Eo, whereas ECF-L selective to BM-Eo did not have such effect. These results suggest that ECF-L selective to PEC-Eo is not simply a chemo-attractant but also is important in eosinophil differentiation.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.